CHINA has developed a new system to treat tumours for which it has obtained independent intellectual property rights.
The Super Gamma System is the first machine with gamma stereotactic radiotherapy in the world to treat both brain and body cancers, said Liu Guangwu, a senior engineer in charge of development.
The system also boasts of high precision, limited side effects and strong radioactivity.
Developed by Shenzhen Hyper Technology Co Ltd and Shenzhen Jiancheng Investment Co Ltd, it has received a production permit from the State Drug Administration.
“Radioactive therapy is an important cancer treatment. WHO statistics show that 45% of tumours can be cured, 22% through surgery, 18% through radioactive therapy and five per cent through medicine,” said Yin Weibo, a professor with the Tumour Hospital under the Chinese Academy of Medical Sciences.
Statistics from China's Institute for Tumour Prevention and Treatment showed China has two million tumour cases each year, of which 1.6 million result in deaths annually.
China lacks adequate equipment to treat cancer, said Yin.
To date, the system has been implemented in the Beijing general hospital for armed police and in the Shandong tumour hospital. – China Daily
Did you find this article insightful?